Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.

Pulmocide recently completed a Phase 2 safety and tolerability clinical trial (OPERA-S study) in lung transplant patients receiving inhaled opelconazole monotherapy as prophylaxis against pulmonary ...

Women are less likely to receive a lung transplant and spend an average of six weeks longer on the waiting list, according to ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges. We ...

Analyst Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report) and increased the price ...

A connection between lung health and kidney function in adults with cystic fibrosis (CF), identifying early urinary markers ...

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) ...

As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists to envision the future of medicine in the year 2050.